NORD believes in the power of collaboration. It is the foundation upon which NORD was built. NORD works with partners in the patient community, government, academia, and industry who share the ultimate goal of identifying, treating, and curing rare diseases.
The Rare Action Network™ is an advocacy network comprised of patients, to their families, caregivers, and friends; from researchers to industry; to physicians and academia. Learn more >
In 2009, NORD entered a strategic partnership with the European Organization for Rare Disorders (EURORDIS), which was just renewed in March, 2015. The goal is to support policies and practices that:
In January 2012, NORD signed a Memorandum of Understanding with the Japan Patients Association, an organization that represents patients with rare and “intractable” diseases (chronic and not responding to treatment) in Japan.
A declaration of shared commitment to improving the lives of rare disease patients and families, the partnership specifies that the two organizations will share information about current advocacy initiatives and seek ways to increase understanding and communication between rare disease patients and patient organizations in Japan and the U.S.
NORD partners with Frontline Medical Communications to provide information about rare diseases to physicians and other healthcare professionals. Recent publications include the following.
NORD collaborates with Medscape on editorial content related to rare diseases and the patient experience. Recent entries include an interview with William Gahl, MD, PhD, Director of the NIH Undiagnosed Diseases Network, on rare disease diagnosis challenges.
NORD works closely with its more than 230 member organizations to provide a united force for advocacy, awareness, education, and research. Through our RareLaunch program, we provide guidance to help organizations grow and meet their goals. Learn more >